Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age
- 29 March 2003
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 197 (1-2) , 11-17
- https://doi.org/10.1016/s0304-3835(03)00076-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neuroblastoma Screening at One Year of AgeNew England Journal of Medicine, 2002
- Outcome of high‐risk neuroblastoma using a dose intensity approach: Improvement in initial but not in long‐term resultsMedical and Pediatric Oncology, 2001
- NeuroblastomaDrugs, 2000
- LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at DiagnosisJournal of Clinical Oncology, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Treatment Results of Advanced Neuroblastoma With the First Japanese Study Group ProtocolJournal of Pediatric Hematology/Oncology, 1999
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.Journal of Clinical Oncology, 1992
- Prognostic Factors in Metastatic NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experienceKlinische Padiatrie, 1990